Financials data is unavailable for this security.
View more
Year on year Quest Diagnostics Inc 's revenues fell -6.38% from 9.88bn to 9.25bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 946.00m to 854.00m, a -9.73% decrease.
| Gross margin | 32.94% |
|---|---|
| Net profit margin | 9.10% |
| Operating margin | 13.13% |
| Return on assets | 5.87% |
|---|---|
| Return on equity | 12.66% |
| Return on investment | 6.77% |
More ▼
Cash flow in USDView more
In 2023, Quest Diagnostics Inc increased its cash reserves by 117.78%, or 371.00m. The company earned 1.27bn from its operations for a Cash Flow Margin of 13.75%. In addition the company generated 160.00m cash from financing while 1.06bn was spent on investing.
| Cash flow per share | 11.87 |
|---|---|
| Price/Cash flow per share | 13.32 |
| Book value per share | 60.79 |
|---|---|
| Tangible book value per share | -31.36 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.25 |
|---|---|
| Quick ratio | 1.17 |
| Total debt/total equity | 0.918 |
|---|---|
| Total debt/total capital | 0.4746 |
More ▼
Growth rates in USD
Year on year, growth in dividends per share increased 7.31% while earnings per share excluding extraordinary items fell by -5.77%. The positive trend in dividend payments is noteworthy since very few companies in the Healthcare Facilities industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.75% |
|---|---|
| Div growth rate (5 year) | 7.43% |
| Payout ratio (TTM) | 38.78% |
| EPS growth(5 years) | 7.78 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 11.75 |
More ▼
